Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Rifampin: A Precision Tool for Transcription Research
2026-08-15
Rifampin is a rifamycin antibiotic that provides a powerful chemical perturbation of bacterial transcription. This article connects its DNA-dependent RNA polymerase mechanism with modern light-controlled gene regulation, emphasizing assay design, resistance interpretation, and research-use limitations.
-
Peptide Dendrimer–Liposome Delivery for mRNA
2026-08-14
The reference study introduces KEL-G1 and KEL-G2 peptide dendrimers combined with DOTAP liposomes to form positively charged nanocomplexes for nucleic acid delivery. These particles supported cellular uptake, mRNA-to-protein expression, siRNA-mediated regulation, and mouse lung delivery, although formulation details and broader in vivo validation remain important next steps.
-
Early Life Adversity, Oxytocin, and Innate Defense
2026-08-14
A 2026 Communications Biology study shows that social deprivation during early postnatal life weakens looming-evoked innate defensive behavior in mice through impaired oxytocin signaling in the superior colliculus. The work connects an early-life environmental exposure to a defined hypothalamus–midbrain circuit and reports intranasal oxytocin as a preliminary rescue strategy, while leaving human translation and broader neuroimmune relevance open for further testing.
-
ARCA Cy5 EGFP mRNA (5-moUTP): Assay Design
2026-08-13
Learn how ARCA Cy5 EGFP mRNA (5-moUTP) separates cellular uptake from productive translation in mammalian delivery studies. This practical framework applies dual fluorescence to evaluate biodegradable carriers, including the 3sPA-LNP platform reported for VEGF mRNA delivery.
-
Adefovir: From HBV Polymerase to Assay Design
2026-08-13
Adefovir and GS-0393 are more than benchmark HBV polymerase inhibitors: they enable carefully separated studies of viral replication, renal transport, and exposure-response relationships. This guide shows how to design and interpret those assays while using host-pathway research as a disciplined translational comparison.
-
Central Opioid Circuits in Mechanical Hypersensitivity
2026-08-12
Yin et al. identify a brain-to-spinal µ-opioid receptor circuit that links repeated morphine exposure to mechanical hypersensitivity and analgesic tolerance in mice. The study distinguishes mechanical pain adaptations from thermal effects and provides a circuit-level framework for investigating opioid-induced pain changes in chronic pain research.
-
Atorvastatin C6405 for Reliable Cell Assays
2026-08-12
This scenario-based guide explains how Atorvastatin (SKU C6405) can support reproducible viability, proliferation, invasion, and mechanistic assays. It connects documented formulation data with vascular biology and ferroptosis literature while emphasizing controls, solvent handling, and cautious interpretation.
-
4μ8C in ER Stress and Hypoxia Research
2026-08-11
4μ8C enables branch-specific interrogation of IRE1α RNase signaling without treating ER stress as a single pathway. This workflow shows how to pair it with PERK–JAK1–STAT3 and pyroptosis assays to distinguish IRE1-dependent effects from broader stress responses in cancer and nucleus pulposus cell models.
-
JAK Inhibitors and Endothelial Cardiovascular Effects
2026-08-11
This 2025 study compared six JAK inhibitors in human endothelial cells exposed to combined TNF and IL-17A, separating shared anti-inflammatory effects from drug-specific vascular responses. The findings show that reduced cytokine release did not consistently translate into lower adhesion or procoagulant signaling, while peficitinib and fedratinib produced endothelial cytotoxicity under the tested conditions.
-
Cediranib (AZD2171) Assay Guide
2026-08-10
A scenario-based guide to using Cediranib (AZD2171), SKU A1882, in viability, proliferation, and VEGFR signaling experiments. It connects assay design, DMSO formulation, pathway readouts, data interpretation, and practical vendor-selection criteria to improve reproducibility in cancer research.
-
Atorvastatin Workflows for Ferroptosis Research
2026-08-09
Atorvastatin is a versatile HMG-CoA reductase inhibitor for connecting cholesterol metabolism research with vascular and cancer-model assays. This guide translates recent ferroptosis findings into practical dosing, assay-selection, sample-handling, and troubleshooting workflows.
-
PEDV Exploits IMPDH to Support Viral Replication
2026-08-08
The reference study shows that porcine epidemic diarrhea virus (PEDV) reprograms host nucleotide metabolism and depends on IMPDH-mediated guanine nucleotide biosynthesis for efficient replication. By combining metabolomics, IMPDH2 knockdown, and Merimepodib (VX-497) treatment, the researchers identify IMPDH as a mechanistically supported host-directed antiviral target.
-
Fucoidan, Irinotecan, and the Gut–Liver Axis
2026-08-07
A 2026 study identifies intestinal barrier failure, LPS translocation, and hepatic neutrophil extracellular traps as a connected pathway in CPT-11-induced steatohepatitis. Its findings position fucoidan as a gut–liver axis intervention that may reduce chemotherapy-associated liver injury while preserving the antitumor context of irinotecan treatment.
-
Sulfo-Cy3 NHS Ester: Hydrophilic Fluorescent Dye for Precisi
2026-08-07
Sulfo-Cy3 NHS ester empowers researchers to achieve high-sensitivity, low-background fluorescent labeling of proteins and peptides—even those with challenging solubility profiles. Its unmatched water solubility and resistance to quenching streamline complex workflows, supporting robust quantitative studies in vascular biology and beyond.
-
Cy5 amine (non-sulfonated): Technical Guidance for Biomolecu
2026-08-06
Cy5 amine (non-sulfonated) addresses the need for a bright, photostable fluorescence dye in workflows where water-insoluble labeling is required. Its amine functionality supports covalent conjugation to proteins, peptides, or polymers, but it is not suitable for direct labeling in aqueous solutions or for diagnostic/clinical applications.